Nebenwirkungen · Phelinun
PHELINUN 50 mg powder and solvent for concentrate for solution for infusion PHELINUN 200 mg powder and solvent for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10–11
HOS-144863 · Präparat HOS-099276
10 MedDRA System Organ Class Frequency Adverse Drug Reactions Nausea, Vomiting, Stomatitis, Gastrointestinal haemorrhage Hepatotoxicity, Uncommon Venoocclusive liver disease Hepatobiliary disorders Liver function test abnormal, Rare Jaundice Very Alopecia after high dose common Common Alopecia after conventional dose Skin and subcutaneous tissue disorders Rash maculo-papular, Uncommon alopecia Rare Pruritus Stevens-Johnson syndrome, Not known Toxic epidermal necrolysis Acute kidney injury, Uncommon Renal failure Renal and urinary disorders Cystitis haemorrhagic, Not known Nephrotic syndrome Amenorrhoea, Ovarian failure, Reproductive system and breast disorders Common Ovarian disorder, Premature menopause, Azoospermia Mucosal inflammation, Common Multiple organ dysfunction General disorders and administration site syndrome, conditions Feeling Pyrexia hot, Uncommon Paraesthesia Investigations Not known Blood creatinine increased
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-06-18T10:27:00Z · SHA-256 03c74603c022c0033a9ba3c60c5cf2b82e17aea5548b8147e82410a78c4a296c · Passage 2484a229698ebd81236942cfee56a2ad2d924a65fa067018e7749de1e35bf37c · Zeichen 5441–8849 im Abschnitt